NCT07287787

Brief Summary

The aim of this study is to compare the clinical efficacy, safety, and technical outcomes of per-oral endoscopid myotomy( POEM )in treatment-naïve achalasia patients versus patients with previous pneumatic dilation.

  • Group I (Naïve group): Patients undergoing POEM as primary therapy.
  • Group II (Prior Pneumatic Dilation group): Patients undergoing POEM after failed or relapsed pneumatic dilation. Data analyzed included the following:
  • Baseline: basic demographic information, Eckardt score , manometry(HRM) , timed barium esophagogram and history of pneumatic dilation .
  • Perioperative parameters (Disease duration, Surgical time, Length of hospital stay, mucosal edema, and mucosal injuries).
  • Intraoperative (mucosal perforation ,bleeding in submucosal space ,pneumoperitoneum ,pneumomediastinum,pneumothorax or incompelet myotomy )and postoperative complications (Infections,esophageal leak ,subcutaneous emphysema, GERD,esophagitis ) .
  • Post procedure symptoms evaluation (Eckardt score) at 1, 3\&6 months after the procedure . Eckardt score : It is a 12-point score which is as following : 0 1 2 3 Recent weight loss (kg) none \<5 kg 5-10 kg \>10 kg Dysphagia none occasional daily each meal Retrosternal chest pain none occasional daily each meal Regurgitation none occasional daily each meal A score of ≥3 is suggestive of active achalasia. POEM technique : Briefly, the procedure included submucosal injection at the 5-6-o'clock position entry point, and mucosal incision at the posterior wall about 8-10 cm above the esophageal-gastric junction (EGJ), entry into the tunnel by clearing submucosal fibers, and then myotomy initiating about 2 cm down from the mucosal incision and extending 2-4 cm into the cardia. Afterwards, the mucosal incision will be closed using endoclips. In special circumstances, when fibrosis or adhesions present because of prior PD, the myotomy will be located in an area of normal (fibrosis-free) tissue, and a long myotomy will be made. Technical success was defined as a successful completion of the entire POEM procedure. Clinical success was defined as a post-POEM Eckardt score of 3.
  • Research outcome measures:
  • Primary (main):
  • Secondary (subsidiary):
  • Technical success
  • Procedure time
  • Intra- and post-operative complications. Data management and analysis : Data will be collected first in sheets, and then will be in Master sheet. Data of every patient will be coded. This will be done using SPSS. Categorical data were presented as number and percentage. Continuous data is presented as mean and standard deviation (SD) if normally distributed or median and interquartile range (IQR) if non normal distributed. Other test will be used according to the results and relations needed to be studied.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
16mo left

Started Dec 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Dec 2025Sep 2027

First Submitted

Initial submission to the registry

November 24, 2025

Completed
21 days until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 17, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

1.3 years

First QC Date

November 24, 2025

Last Update Submit

December 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical success at 3 and 6 months (Eckardt score ≤ 3 )

    6 months

Secondary Outcomes (3)

  • - Technical success

    1 day ( the day of the procedure )

  • procedure time

    1 day ( the day of the procedure)

  • Intraoperative & post operative complications

    up to 6 months after the procedure

Study Arms (2)

Group I (Naïve group): Patients undergoing POEM as primary therapy.

ACTIVE COMPARATOR
Procedure: per-oral endoscopic myotomy (POEM)

- Group II (Prior Pneumatic Dilation group):Patients undergoing POEM after failed pneumatic dilation

ACTIVE COMPARATOR
Procedure: per-oral endoscopic myotomy (POEM)

Interventions

Briefly, the procedure included submucosal injection at the 5-6-o'clock position entry point, and mucosal incision at the posterior wall about 8-10 cm above the esophageal-gastric junction (EGJ), entry into the tunnel by clearing submucosal fibers, and then myotomy initiating about 2 cm down from the mucosal incision and extending 2-4 cm into the cardia. Afterwards, the mucosal incision will be closed using endoclips. In special circumstances, when fibrosis or adhesions present because of prior PD, the myotomy will be located in an area of normal (fibrosis-free) tissue, and a long myotomy will be made.

- Group II (Prior Pneumatic Dilation group):Patients undergoing POEM after failed pneumatic dilationGroup I (Naïve group): Patients undergoing POEM as primary therapy.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients diagnosed with achalasia (Chicago classification types I-III by High resolution manometry (HRM) ).

You may not qualify if:

  • Children below 18 yr.
  • Prior surgical myotomy.
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Esophageal Achalasia

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized control trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer at internal medicine department - faculty of medicine - Assiut university

Study Record Dates

First Submitted

November 24, 2025

First Posted

December 17, 2025

Study Start

December 15, 2025

Primary Completion (Estimated)

April 15, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

December 17, 2025

Record last verified: 2025-12